← Open Payments lookup

SHALINI MANSHARAMANI: Open Payments

NPI 1518954031 · TAUNTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,316 in 112 payments from 15 companies in 2025. Trend: 2023 $851 · 2024 $1,576 · 2025 $2,316

Food & beverage: $2,316
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.19$403
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$361
Vanda Pharmaceuticals Inc.12$331
Alkermes, Inc.12$321
ABBVIE INC.15$234
Lundbeck LLC10$209
Janssen Pharmaceuticals, Inc7$140
E.R. Squibb & Sons, L.L.C.5$108
Neurocrine BioSciences, Inc.4$73
Sage Therapeutics, LLC2$44

Products named: REXULTI, CAPLYTA, FANAPT, VRAYLAR, ARISTADA, LYBALVI, INVEGA SUSTENNA, INGREZZA.

Industry payments across MA — which companies pay providers there.